Mechanisms by which antimicrobials contribute to dissemination of pneumococcal resistance are incompletely characterized. A serial cross-sectional study of nasopharyngeal pneumococcal carriage in healthy, home-living children 6 years of age was conducted in four rural communities-two in Utah (1998Utah ( -2003 and two in Idaho (2002Idaho ( -2003. Prevalence odds ratios for carriage of resistant pneumococci (OR res ) and of susceptible pneumococci (OR sus ) were estimated. Dynamic transmission models were developed to facilitate a mechanistic interpretation of OR res and OR sus and to compare the population impact of distinct antimicrobial classes. A total of 5,667 cultures were obtained; 25% of the cultures were positive, and 29% of isolates exhibited reduced susceptibility to penicillin. The adjusted OR res for recent individual and sibling cephalosporin use was 2.2 (95% confidence interval: 1.4, 3.4) and 1.8 (95% confidence interval: 1.0, 3.3), respectively. Neither individual nor sibling penicillin use was associated with increased OR res . Rather, recent use of penicillins was associated with decreased carriage of susceptible pneumococci (OR sus ¼ 0.2, 95% confidence interval: 0.1, 0.3). In simulations, both types of effects promoted dissemination of resistant pneumococci at the population level. Findings show that oral cephalosporins enhance the risk of acquiring resistant pneumococci. Penicillins accelerate clearance of susceptible strains. The effect of penicillins in increasing resistance is shared equally by treated and untreated members of the population.
. The mechanisms by which antimicrobial agents contribute to the spread of resistance in human populations are incompletely understood.
We conducted a study to compare the effects of individual antimicrobial drug classes on carriage of S. pneumoniae. Two broad goals motivated this study. The first objective was to test the hypothesis that the relative risks for carriage of susceptible and resistant pneumococci would vary across drug classes as a consequence of differences in antimicrobial activities. The second was to assess the impact of distinct antimicrobial classes on dissemination of resistant S. pneumoniae at a population level.
This study was conducted in three parts. First, using data prospectively collected from a large population of healthy children in rural communities and statistical methods that accounted for household clustering, age, and other factors, we estimated the odds ratios for carriage of resistant and susceptible S. pneumoniae for three classes of antimicrobial agents. Second, using mathematical models, we related the values of the odds ratios to specific antimicrobial effects on acquisition and clearance of S. pneumoniae. Third, also using models, we examined the relation between these antimicrobial effects and the community spread of pneumococcal resistance.
MATERIALS AND METHODS

Study population
Healthy, home-living, rural community residents were recruited to participate in an annual survey of nasopharyngeal S. pneumoniae carriage in children between the ages of 6 months and 6 years. The annual surveys were performed during the period 1998-2004 in two Utah communities and from 2002 to 2004 in two Idaho communities. The results presented here encompass the period 1998-2003. The size of the community populations studied ranged from 5,000 to 35,000. Techniques to solicit household participation in the project included media coverage in local newspapers and distribution of informational flyers. Field teams performed the cultures either in the homes of participating families or in recruiting stations set up in community shopping centers and pharmacies. Cultures were collected between February and May of each year.
The University of Utah Institutional Review Board granted approval for the study. Written informed consent was obtained from all participants.
Microbiologic procedures
Nasopharyngeal cultures were collected as previously described (16) . The field teams consisted of health-care personnel who were trained in the technique of obtaining nasopharyngeal cultures. The swab was inserted into the child's nasopharynx, rotated gently, and removed. The swabs were then placed immediately into the accompanying transport media. At the end of each collection day, the swabs were transported by courier to a central laboratory (Associated and Regional University Pathologists Laboratories, Salt Lake City, Utah) for processing.
All swabs were processed as previously described (16) . Briefly, swabs were inoculated onto 5 percent Columbia sheep blood agar plate with and without gentamicin. Isolates identified as S. pneumoniae were tested for susceptibility by using the E-test (AB Biodisk, Solna, Sweden). Results of testing to the following agents are described here: penicillin, ceftriaxone, and erythromycin. Categorical interpretations for the minimal inhibitory concentration values were assigned by using Clinical and Laboratory Standards Institute (formerly NCCLS) break points (17) . Pneumococci with intermediate susceptibility to penicillin (minimal inhibitory concentration: 0.12-1.0 lg/ml) were classified as betalactam resistant for purposes of epidemiologic analysis; other minimal inhibitory concentration break points are given in appendix table 1.
Data collection
A questionnaire was administered to parents to collect demographic and exposure data. Information about antimicrobial prescriptions during the 6-month period prior to culture was collected directly from community retail pharmacies. Antimicrobial prescriptions were classified by time interval according to the date on which the prescription was filled and the date of culture. When the duration of the prescription encompassed the culture date, the culture was classified as being obtained during antimicrobial treatment. Child care was defined as regular attendance in a group child-care setting outside of the home or school for an average of 2 or more hours a day, Monday through Friday. Data on heptavalent conjugate vaccine use were collected from the medical records of individual children and from community health centers where vaccines were administered.
Data and statistical analysis
Measures of relative risk. Carriage of S. pneumoniae, divided on the basis of antimicrobial susceptibility, constituted the study endpoint. Risk factors of primary interest were antimicrobial treatments. The prevalence odds ratio was calculated as the odds of carriage for those exposed (i.e., antimicrobial-treated individuals) divided by the odds of carriage for those unexposed (i.e., nontreated individuals). Three types of prevalence odds ratios were estimated according to whether children carried resistant or susceptible S. pneumoniae. The first type of prevalence odds, OR res , was computed by dividing the odds of carriage of resistant pneumococci for exposed individuals by the odds of such carriage for unexposed individuals (note that this type of odds ratio was labeled OR S in Lipsitch (18) ). The second type, OR sus , represented the odds of carriage of susceptible pneumococci for exposed individuals divided by the odds of such carriage for nonexposed individuals. The third type, OR C , was calculated as the odds of exposure for resistant carriers divided by the odds of exposure for susceptible carriers (18) . The ratio of OR res to OR sus approximates OR C . When OR C for an antimicrobial drug is greater than one, it means that, given pneumococcal carriage, the organism is more likely to be resistant if the individual was exposed to the antimicrobial. Regression models. Multilevel logistic regression was used to account for clustering by household and to estimate OR res , OR sus , and OR C adjusted for age, household size, community, and year (19) (20) (21) (22) . Variables were selected for inclusion in the final model on the basis of the Wald test statistic (p < 0.05) or a change in effect estimate of more than 15 percent for other factors or because they were judged a priori to be necessary for adjustment. First-order penalized quasi-likelihood was used as the estimation procedure. Multilevel regression models were fit by using MLwiN version 2.0 software (Centre for Multilevel Modelling, University of Bristol, Bristol, United Kingdom). Other statistical analyses were performed by using Stata version 8.0 software (Stata Corporation, College Station, Texas).
Dynamic transmission models
Deterministic model. A compartmental model was developed to provide a framework for mechanistic interpretation of the measures of relative risk listed above (18, 23, 24) (Appendix). Six states were formulated according to 1) pneumococcal carriage status (carriage of resistant or susceptible pneumococci and noncarriage); and 2) antimicrobial use (whether or not using an antimicrobial agent) (25) . The model posits that noncarriers acquire resistant or susceptible pneumococci following contact with carriers of resistant pneumococci or susceptible pneumococci, respectively. During the period of treatment, antimicrobial agents differentially affect acquisition of resistant and susceptible pneumococci. Antimicrobial treatment is presumed to accelerate loss of carriage of susceptible organisms to a greater extent than resistant organisms.
Stochastic model. An individual-agent (microsimulation) version of this compartmental model was also constructed. This method treated transitions between states as discrete events that occurred probabilistically rather than deterministically. A benefit of the individual-agent model was that it made it easier to incorporate nonexponential distributions for parameters such as duration of antimicrobial courses. Another advantage was that it accommodated the modeling of a posttreatment effect of antimicrobial therapy.
Parameters were set according to observed or published data where possible (26) . In the base model, the population was constituted to comprise a single pediatric age range, with prevalence of carriage and antimicrobial use comparable to that among young children. Thus, the average prevalence of antimicrobial use was set at 4 percent, and the initial prevalence of susceptible and resistant carriage was assumed to be 18 percent and 7 percent, respectively.
The population attributable fraction was calculated from simulation models by comparing the total number of resistant acquisitions generated during a 6-month period run under different conditions of antimicrobial use. The population attributable fraction for penicillins was calculated as the number of resistant infections under base conditions (antimicrobial use set at the observed ratio of three times more penicillins than cephalosporins) minus the number of infections when penicillin use was zero, divided by the number of resistant infections under base conditions. The population attributable fraction for cephalosporins was calculated similarly, by comparing the number of resistant infections under base conditions with the setting of zero cephalosporin use.
Five thousand runs of the simulation model were generated for each variation in conditions or parameters. Further details about the construction of the individual-agent model are included in the Appendix (27) .
RESULTS
Description of the population
A total of 5,667 cultures were obtained during the 6-year period from 1998 to 2003, representing 3,656 unique children and 2,123 unique households. Sixty-five percent of the children participated once, 22 percent twice, 7 percent three times, 4 percent four times, 1 percent five times, and 0.4 percent six times.
Overall, 1,392 (25 percent) of the cultures were positive for S. pneumoniae, of which 409 (29 percent) exhibited reduced susceptibility to penicillin, 263 (19 percent) resistance to erythromycin, and 54 (4 percent) resistance to ceftriaxone. Ten percent of the isolates had a minimal inhibitory concentration to penicillin of 2. Eighty-seven percent of erythromycin-resistant isolates were also intermediate or resistant to penicillin. In 56 percent of instances, isolates exhibiting reduced susceptibility to penicillin were also resistant to erythromycin.
The most commonly used antimicrobial drugs were penicillins (58 percent of antimicrobial courses), followed by cephalosporins (19 percent) and macrolides (19 percent) (refer to appendix table 2 for details). The mean duration of an antimicrobial prescription was 9 days. Eighty-seven percent of cephalosporin and penicillin prescriptions were for 10 days. During the months January-April, an average of 4 percent of children were using antimicrobials on any given day.
Factors associated with resistant and/or susceptible carriage
Cephalosporins, but not penicillins, were associated with increased beta-lactam-resistant carriage. The prevalence of carriage of beta-lactam-resistant S. pneumoniae was 15 percent (30 of 195) among children who had used cephalosporins within 30 days, 7.5 percent (36 of 478) among children who had used penicillins within 30 days, and 6.8 percent (333 of 4,867) among children who had not used an antimicrobial within 30 days. Thus, children recently treated with cephalosporins were 2.2-fold more likely than children who had not recently used cephalosporins to be beta-lactam-resistant carriers, whereas the frequency of carriage of resistant pneumococci among children who recently used penicillins was similar to that for non-penicillin-treated children. The corresponding OR res adjusted for household clustering, age, year, and community and other factors were 2.2 and 0.9, respectively (table 1). The results were similar regardless of whether intermediately susceptible pneumococci were classified as resistant. The cephalosporin and penicillin OR res for carriage of fully resistant S. pneumoniae were 2.2 and 1.0, respectively. The largest effect of antimicrobials on resistant and susceptible carriage was observed when cultures were obtained within 10 days after therapy was initiated. Expressed another way, the values of OR res and OR sus were highest or lowest (e.g., most deviated from one) when determined on the basis of antimicrobial prescriptions given within 10 days prior to the culture date. Figure 1 depicts the OR res and OR sus for cephalosporins and penicillins measured across successive intervals between date of prescription and date of culture. The adjusted OR res for cephalosporins decreased sharply toward one when the culture was obtained more than 10 days after therapy was initiated. Thirteen of the 17 children who had used cephalosporins 1-10 days prior to culture and who were beta-lactam-resistant carriers had been treated with cefdinir or cefixime. Conversely, the adjusted OR sus for penicillins trended upward gradually, reaching one at the 61-90-day interval.
Antimicrobial use after the culture date was not associated with pneumococcal carriage. An analysis was also performed of antimicrobials prescribed after the culture was collected to test the proposition that the findings were spurious. If the adjusted associations were due to confounding rather than causal effects of distinct antimicrobial classes on pneumococcal carriage, antimicrobials prescribed after collection of the culture should also be associated with carriage. Use of neither penicillin nor cephalosporins 1-10 days after culture was associated with resistant carriage Recent treatment with cephalosporins, penicillins, and macrolides was more common among resistant carriers than susceptible carriers, an association gauged by OR C . The adjusted OR C for recent cephalosporin and penicillin use, estimated by comparing carriers of beta-lactam-resistant pneumococci with carriers of beta-lactam-susceptible pneumococci, were 3.0 (95 percent CI: 1.6, 5.9) and 4.0 (95 percent CI: 2.1, 7.5), respectively. The adjusted OR C for macrolide use, estimated by comparing carriers of erythromycin-resistant pneumococci with carriers of erythromycinsusceptible pneumococci, was 6.2 (95 percent CI: 2.2, 17.5).
The OR C for macrolide use and beta-lactam resistance was 6.2 (95 percent CI: 2.3, 19.6), and the OR C for penicillin use and erythromycin resistance was 2.9 (95 percent CI: 1.6, 5.3). The elevated OR C in these instances was explainable on the basis of the correlation between beta-lactam and macrolide resistance. Stratifying on the presence or absence of co-resistance to macrolide reduced the OR c for macrolide treatment and beta-lactam resistance to 1.2. Stratifying on the presence or absence of co-resistance to penicillin reduced the OR c for penicillin treatment and erythromycin resistance to 1.1.
Prior carriage of beta-lactam-resistant or -susceptible pneumococci, detected by previous participation in the surveillance study, was associated with susceptible carriage (OR sus for prior susceptible carriage ¼ 1.4, OR sus for prior resistant carriage ¼ 1.7). In contrast, neither prior carriage of resistant nor prior carriage of susceptible pneumococci was associated with resistant carriage (table 1). Younger age was more strongly associated with carriage of betalactam-resistant pneumococci than with carriage of betalactam-susceptible pneumococci (table 1) . Prior heptavalent conjugate vaccine use also was not associated with decreased carriage (table 1) .
Use of transmission models to interpret the observed results
The association between cephalosporin use and carriage of resistant pneumococci denoted an effect to enhance acquisition of beta-lactam-resistant pneumococci. The transmission model was used to derive generalizations about the circumstances under which OR res exceeds one: either therapy favors acquisition of resistant organisms, compared with the non-antimicrobial-treated state, and/or therapy slows down the rate of clearance of resistant organisms, compared with the non-antimicrobial-treated state (figure 2). However, the maximum increase in OR res caused just by delayed clearance is modest.
OR res for recent penicillin therapy was close to one, suggesting that penicillins at the doses prescribed to children in this study enhanced acquisition of beta-lactam-resistant pneumococci only minimally, if at all. model was also used to derive generalizations about the circumstances under which OR sus is less than one. Figure 3 demonstrates that either diminished acquisition of susceptible organisms or accelerated clearance of susceptible organisms leads to a lowering of OR sus . However, the lowering of OR sus achieved by effects on acquisition alone is modest.
Simulations of community populations demonstrated that both types of antimicrobial effects could promote dissemination of resistant S. pneumoniae in a community population. A population of 1,000 children was simulated in which only the penicillin class of antimicrobials was used. During the period of treatment, penicillin was assumed to enhance clearance of susceptible pneumococci 10-fold and resistant pneumococci 1.2-fold during therapy (refer to appendix tables 3 and 4 for other base-case parameter values). Acquisition of resistant pneumococci was assumed to be unaffected. These parameter values were selected for illustrative purposes, not on the basis of maximum likelihood estimation or other methods of model fitting.
When 5,000 simulations of the individual-agent model were run by using these parameters, resistant carriage rose from a median of 7 percent (2.5th, 97.5th percentile: 6, 9) at baseline to a median of 12 percent (2.5th, 97.5th percentile: 5, 20) at 6 months (figure 4). The median OR sus and OR res from the simulations were 0.3 (2.5th, 97.5th percentile: 0.1, 0.6) and 1.0 (2.5th, 97.5th percentile: 0.5, 1.8), similar to the observed OR sus and OR res for penicillins. The same simulation model was rerun by replacing penicillins with cephalosporin-class antimicrobials. The parameters representing the antimicrobial effects were altered, and other parameter values were left unchanged. During treatment, cephalosporin therapy was assumed to reduce acquisition of susceptible pneumococci following contact by 30 percent and to increase acquisition of beta-lactam-resistant pneumococci fourfold (refer to appendix table 3). Resistant carriage rose from 7 percent at baseline to 20 percent (2.5th, 97.5th percentile: 12, 28) at 6 months (figure 4). The median OR sus and OR res from the simulations were 0.7 (2.5th, 97.5th percentile: 0.4, 1.2) and 1.7 (2.5th, 97.5th percentile: 1.0, 2.7).
The model was then applied to compare the population impact of the two antimicrobial classes by simulating a population in which both drugs were used. The prevalence of penicillin use was set at 3 percent and of cephalosporin use at 1 percent to correspond to actual practice. Other parameters were the same as described above. These conditions produced a median of 715 (2.5th, 97.5th percentile: 406, 1,046) transmissions (infections) with resistant pneumococci during a 6-month follow-up period. When the same model was run by reducing the prevalence of penicillin use to zero but continuing the same level of cephalosporin use, a median of 607 (2.5th, 97.5th percentile: 343, 918) infections were observed; when the model was run by setting cephalosporin use to zero but continuing the same penicillin use, the median number of infections during 6 months was 606 (2.5th, 97.5th percentile: 342, 907). Thus, each drug class had an estimated population attributable fraction of 15 percent. Clearance multiplicative factor ( R ) Clearance multiplicative factor ( S ) FIGURE 3. Results of a two-way sensitivity analysis used to develop deterministic-model-derived prevalence odds ratios for carriage of susceptible pneumococci (OR sus ) based on antimicrobial effects on acquisition and clearance of resistant organisms. ms, multiplicative effect of the antimicrobial in decreasing the probability that an individual will acquire a susceptible organism given contact with an infectious individual; values <1 indicate that, compared with the nontreated state, the antimicrobial agent inhibits acquisition of susceptible organisms. d S , multiplicative factor by which antimicrobial treatment accelerates clearance of susceptible organisms. Refer to the Appendix for details.
Possible occurrence of co-carriage of resistant and susceptible strains and its implication with respect to OR sus and OR res was also evaluated. The conditions of the cephalosporin-only model were changed to stipulate that 25 percent of susceptible carriers were also colonized with a subpopulation of beta-lactam-resistant S. pneumoniae. The mean duration of days from initiation of antimicrobial agents to selection of the resistant subpopulation was set at 3 for individuals who co-carried susceptible and resistant pneumococci. With other parameters set at the same values as in the cephalosporin simulation, OR res was 1.9 (2.5th and 97.5th percentiles: 1.2, 3.0). The median OR sus was 0.5 (2.5th and 97.5th percentiles: 0.2, 0.8). Resistant carriage at 6 months rose to 23 percent (2.5th and 97.5th percentiles: 15, 30).
DISCUSSION
The results of this study support the hypothesis that distinct antimicrobial classes promote pneumococcal resistance by different mechanisms. Individual and sibling use of cephalosporin increases the individual risk of resistant carriage by enhancing acquisition of new resistant pneumococcal strains during or shortly after treatment. In contrast, penicillins do not enhance individual risk of carriage of resistant S. pneumoniae. Rather, penicillins markedly accelerate clearance of susceptible pneumococci (5, 28) . Both antimicrobial drug classes promote population dissemination of resistant pneumococci, but, in the case of penicillins, the elevated risk of resistant carriage is shared equally by treated and untreated members of the population.
This sharp contrast between cephalosporins and penicillins may, in part, be a function of the predominant oral cephalosporins prescribed in these communities, cefdinir and cefixime (29) (30) (31) . Cefixime has particularly poor activity against pneumococci and also is broad spectrum. Macrolides appeared to combine effects of the penicillin and cephalosporin drug classes: they accelerated clearance of susceptible S. pneumoniae similar to penicillins while exhibiting no evidence of activity against erythromycin-resistant pneumococci (32, 33) . Although not statistically significant, the trend toward an association between macrolide use and erythromycinresistant pneumococcal carriage suggested that macrolides may also enhance acquisition of resistant organisms (34) . Because of co-resistance, macrolides promote dissemination of beta-lactam resistance, and beta-lactams enhance spread of macrolide resistance (35, 36) .
Limitations of the study design should be acknowledged. Minor discrepancies are frequent between the E-test method for susceptibility testing and microbroth dilution testing (27, (37) (38) (39) (40) . However, the differences rarely affect the categorical interpretation of susceptibility. Furthermore, the results of the regression models were similar whether or not isolates with intermediate susceptibility were classified as resistant. Another drawback was that the small number of communities precluded an analysis of the relation between communitylevel antimicrobial use and pneumococcal resistance. A strength of the study was that healthy children were recruited from home settings rather than from within healthcare or day-care facilities (41) (42) (43) (44) (45) (46) (47) (48) (49) . Lastly, the study design did not permit a detailed examination of antimicrobial drug effects at a pharmacodynamic or concentration-specific level (50) .
Penicillin-resistant pneumococcal clones have disseminated to multiple continents (2, 6, 51) . These clones possess mosaic penicillin-binding protein genes that contain interspersed sequences of foreign DNA (1). Decreased susceptibility to cephalosporins has also been associated with point mutations of specific penicillin-binding proteins (52) . When the simulation model was modified to account for the possibility of emergence of resistant organisms through mutation or through selection of resistant strains among individuals who carry multiple strains (53-57), inferences were not materially altered. Emergence of resistance in the individually treated host is likely to be more important at a stage when resistance is rare and when antimicrobial treatment and carriage are more closely linked.
In summary, the data and models show that oral penicillins promote pneumococcal resistance primarily by enhancing clearance of susceptible pneumococci, and that this mechanism gives resistant pneumococci a competitive advantage at the population level. In contrast, the oral cephalosporins appear to directly increase acquisition of resistant S. pneumoniae. The models demonstrate that both types of effects contribute to dissemination of resistant strains. Thus, it is not necessary for antimicrobials to increase an individual's risk of resistant carriage or infection for the antimicrobial to select for resistant organisms at a population level (58) . An appropriate . Adjacent values were calculated by using the interquartile range (IQR), which is the difference between the 75th and 25th percentiles. The upper adjacent value is the largest data point that is less than or equal to the third quartile plus 1.5 3 IQR; the lower adjacent value is the smallest data point that is greater than or equal to the first quartile minus 1.5 3 IQR. Refer to the text and the Appendix for a detailed description of the structure of the individual-agent model.
message to be drawn is that narrow-spectrum antimicrobial agents that exhibit highly targeted activity still can cause plenty of damage with respect to resistance. The broader conclusions are that both susceptible and resistant carriage should be evaluated in epidemiologic studies of resistant organisms and that all antimicrobial drug classes ultimately impact resistance, albeit to varying degrees. An intervention strategy of simultaneously lowering unnecessary use of even narrow-spectrum drugs while redirecting choice away from agents with broader-spectrum activity is likely to be most effective at mitigating the public health threat of antimicrobial resistance.
transmission rate parameters for susceptible and resistant organisms are b AS and b AR , respectively. The model is formulated to assume that susceptible carriers are noninfectious during antimicrobial treatment because of reduction in organism burden and viability.
To produce the graphs in figures 2 and 3, the initial prevalence of carriage of resistant pneumococci was set at 8.4 percent, susceptible pneumococci at 12.7 percent, and antimicrobial use at 4.2 percent. The rate of starting antimicrobials (a) was fixed at 0.005 and the rate of stopping antimicrobials (e) at 0.1. Prevalence odds ratios were calculated after simulating 60 days of follow-up.
Stochastic model
The individual-agent (microsimulation) version of this compartmental model treated transitions between states as discrete events that occurred probabilistically rather than deterministically. An advantage of this approach was that it more easily accommodated the modeling of a posttreatment effect of antimicrobial therapy. Such an effect would be mediated by antimicrobial-induced suppression of nasopharyngeal flora that otherwise inhibits acquisition of new bacteria and presumably lasts until normal flora are restored. Following antimicrobial treatment, increased susceptibility to acquisition of new strains, if present, should extend to both susceptible and resistant pneumococci. Another benefit of the individual-agent model is that it made it easier to incorporate nonexponential distributions for parameters such as duration of antimicrobial courses.
The individual-agent model was constructed in AnyLogic 5.1 (XJ Technologies, St. Petersburg, Russia) by using Javabased code to create replicated objects to represent members of a population. Individuals transitioned between carrier and noncarrier states and between antimicrobial-treated and nonantimicrobial-treated states. An individual carrier contacted randomly selected individual noncarriers at time intervals derived from an exponential distribution; each contact event resulted in transmission with a probability determined by a log-linear equation that included terms for antibiotic status of the potential transmitter and potential recipient.
A simplifying assumption of the models used for simulation was that resistance had zero fitness costs; that is, in the absence of antimicrobial use, transmission and clearance rate parameters were equal for resistant and susceptible strains. Because of these assumptions, the rate at which resistance rose in the simulations was faster than what is observed in actual human populations. Using more complex models did not alter the interpretation of the model regarding antimicrobial effects.
